Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03756350 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)
A NA study of Fat Atrophy, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT03756350: Completed NA study of Fat Atrophy, sponsored by Venus Concept.
NCT03756350 is a NA study of Fat Atrophy that has completed, run by Venus Concept. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03756350, a NA study of Fat Atrophy, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is evaluating a 1060nm diode laser for non-invasive fat reduction of the abdomen. The study will enrolled up to 50 subjects requesting non-invasive lipolysis of the abdomen. Each subject will receive a single study treatment. Subjects will be followed at six and twelve weeks post treatment. Twelve week outcomes will be compared to baseline.
Primary Outcome
Photographic evaluation by independent blinded evaluators with correct identification of pre-treatment baseline images when compared to post-treatment images taken at 12 weeks
Conditions Studied
Interventions
- DEVICE 1060nm diode laser
Study Locations (2)
California
- Laser and Skin Surgery Center of Northern California - Sacramento
Texas
- Southwestern Medical Center Department of Plastic Surgery - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2019-07-02 |
| Phase | NA |
What the finished NCT03756350 record still lists
NCT03756350 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Fat Atrophy appearing as the primary indexed condition, and to 1 intervention - of which 1060nm diode laser is the first listed.
NCT03756350 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT03756350 about?
NCT03756350 is a clinical study titled "Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)". This study is evaluating a 1060nm diode laser for non-invasive fat reduction of the abdomen. The study will enrolled up to 50 subjects requesting non-invasive lipolysis of the abdomen. Each subject will receive a single study treatment. Subjects will be followed at six and twelve weeks post treatmen...
What is the current status of trial NCT03756350?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-11-14. Estimated completion is 2019-07-02.
What conditions does trial NCT03756350 study?
This clinical trial studies the following conditions: Fat Atrophy.
What interventions are being tested in trial NCT03756350?
The interventions under investigation include: 1060nm diode laser (DEVICE).
Who is sponsoring clinical trial NCT03756350?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03756350 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03756350's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI